Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
19th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Categories
Categories
Actinogen (ACW)
Adalta (1AD)
Anteris Technologies (AVR)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Botanix (BOT)
Chimeric Therapeutics (CHM)
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Dimerix (DXB)
Immuron (IMC)
Imugene (IMU)
Island Pharmaceuticals (ILA)
Neuren Pharmaceuticals (NEU)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
June 3rd, 2022
Patrys - Can Its Antibodies Prevent Metastases?
Read More
June 3rd, 2022
Dimerix - Structural Regulatory Changes in Kidney Diseases Perfect Timing
Read More
May 25th, 2022
Chimeric Antigen Receptor T Cell Therapies
Read More
May 25th, 2022
Bioshares Biotech Summit Conference Coverage - Cogstate
Read More
May 3rd, 2022
Cogstate Reports Record - Sales Up 105%
Read More
April 1st, 2022
Radiopharm Theranostics - Update
Read More
April 1st, 2022
Chimeric Therapeutics Raises $14 Million in Rights Issue
Read More
February 28th, 2022
Anteris Technologies Declines Merger Proposal
Read More
February 28th, 2022
Cogstate Half-Year Results
Read More
February 14th, 2022
Pharmaxis Update
Read More
February 14th, 2022
Chimeric Therapeutics Reports Good Data in Second Patient Cohort
Read More
February 14th, 2022
Anteris Technologies Declines Merger Proposal
Read More
February 14th, 2022
Why Horizon 3 Biotech Investment Committee like EBR Systems
Read More
January 28th, 2022
Cogstate - US$13.7 Million of Sales Contracts Signed
Read More
July 27th, 2021
Adalta Moves to Inhaled Delivery for AD-214
Read More
June 15th, 2021
Adalta Progresses GE Collaboration and Sets Clear Milestones for Path Ahead
Read More
March 15th, 2021
Adalta Phase Ia Results – Multiple Positive Findings
Read More
February 15th, 2021
Adalta’s Prospects Improve
Read More
Pages
1
2
3
4
5
6
7
8
9
